Literature DB >> 8791135

Tumoral vascularity as a prognostic factor in cancer.

N Weidner1, J Folkman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8791135

Source DB:  PubMed          Journal:  Important Adv Oncol        ISSN： 0883-5896


× No keyword cloud information.
  34 in total

Review 1.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

2.  Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.

Authors:  Masaru Kubota; Takamichi Murakami; Hiroaki Nagano; Hidetoshi Eguchi; Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Masahiro Tanemura; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden; Masaki Mori; Yuichiro Doki
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

3.  Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy.

Authors:  C J Dimitroff; W Klohs; A Sharma; P Pera; D Driscoll; J Veith; R Steinkampf; M Schroeder; S Klutchko; A Sumlin; B Henderson; T J Dougherty; R J Bernacki
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

4.  1'-Acetoxychavicol acetate suppresses angiogenesis-mediated human prostate tumor growth by targeting VEGF-mediated Src-FAK-Rho GTPase-signaling pathway.

Authors:  Xiufeng Pang; Li Zhang; Li Lai; Jing Chen; Yuanyuan Wu; Zhengfang Yi; Jian Zhang; Weijing Qu; Bharat B Aggarwal; Mingyao Liu
Journal:  Carcinogenesis       Date:  2011-03-22       Impact factor: 4.944

5.  Target therapy using a small molecule inhibitor against angiogenic receptors in pancreatic cancer.

Authors:  Peter Büchler; Howard A Reber; Mendel M Roth; Mark Shiroishi; Helmut Friess; Oscar J Hines
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

6.  Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.

Authors:  Basel Sitohy; Sunghee Chang; Tracey E Sciuto; Elizabeth Masse; Mei Shen; Peter M Kang; Shou-Ching Jaminet; Laura E Benjamin; Rupal S Bhatt; Ann M Dvorak; Janice A Nagy; Harold F Dvorak
Journal:  Am J Pathol       Date:  2017-07-21       Impact factor: 4.307

7.  Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin.

Authors:  Aditi Banerjee; Jing-Yu Lang; Mien-Chie Hung; Krishanu Sengupta; Sushanta K Banerjee; Krishna Baksi; Dipak K Banerjee
Journal:  J Biol Chem       Date:  2011-06-15       Impact factor: 5.157

Review 8.  Chemokines: novel targets for breast cancer metastasis.

Authors:  Simi Ali; Gwendal Lazennec
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

9.  Open-label, phase I dose-escalation study of sodium selenate, a novel activator of PP2A, in patients with castration-resistant prostate cancer.

Authors:  N M Corcoran; C M Hovens; M Michael; M A Rosenthal; A J Costello
Journal:  Br J Cancer       Date:  2010-07-20       Impact factor: 7.640

10.  Mechanism of IL-12 mediated alterations in tumour blood vessel morphology: analysis using whole-tissue mounts.

Authors:  S A Gerber; J P Moran; J G Frelinger; J A Frelinger; B M Fenton; E M Lord
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.